This engagement highlights the ongoing evolution of Ariadne
Rockville, MD, and Paris, France (PRWEB) May 25, 2010
Ariadne and Aureus are joining forces with the goal to deliver leading knowledge management solutions for the life sciences industry, and announce that Ariadne will distribute Aureus' offerings in the US.
The two companies will initiate a collaboration to explore together further synergies between their respective knowledge management solutions and more particularly the interfaces between the protein pathway space and medicinal chemistry. Such interfaces will help customers to better understand mechanisms of actions between therapeutic proteins, protein pathways and small molecules and provide new insights in the disease biology area.
"This engagement highlights the ongoing evolution of Ariadne," says Ilya Mazo, Ph.D. and CEO, "by partnering with best-in-class providers of knowledge management solutions. We can provide solutions that enable customers to take advantage of both Ariadne and Aureus' products where it makes sense in their organization, workflow and informatics infrastructure. We believe that this collaboration will make it possible to offer the highest level of interoperability between our companies, along with improved solutions for knowledge management."
"The partnership between Aureus and Ariadne will enable to support synergies in discovery and development workflows as used across multiple departments and scientific disciplines in the Life Science Industry," says Jason Theodosiou, CEO of Aureus Pharma. "Both companies are innovative and have created solutions that organize high quality data from various sources to better identify, create, distribute, and enable knowledge integration within an organization."
The collaboration will establish confidence between researchers in disease biology and medicinal chemistry that the technologies they use and deploy in their specific environments provide continuity in the pipeline discovery process, align common goals in knowledge management and increase scientific comprehension between these two groups.
Financial terms were not disclosed.
Ariadne (http://www.ariadnegenomics.com), a leader in bioinformatics, designs and develops software and knowledge integration solutions for pharmaceutical and life science researchers. Pathway Studio, Ariadne's premier software product is an integrated database, supporting multiple omics profiling technologies, text mining, and experimental data analysis tools that provide an interactive scaffold for defining and testing in silico-based hypotheses across a wide range of disciplines.
Pathway Studio includes a family of ResNet® databases of biological relationships and curated pathways, both canonical and expert driven. The databases are powered by MedScan® technology, which researchers can use to edit and enhance database content from current literature and by adding proprietary data, experimental data from multiple omics profiling technologies and biological relationships, creating a unique and focused knowledgebase. A wide range of applications are supported including mechanistic modeling of disease, drug action and toxicity, as well as biomarker discovery, cellular and network pathway building, protein-protein interactions and much more. Pathway Studio is available in desktop and enterprise versions.
About Aureus Pharma
Aureus Pharma provides a range of scientific knowledge solutions enabling biopharmaceutical companies to better understand the relationships of biological targets to compounds under evaluation. Aureus scientists continuously monitor and organize the most relevant information from the scientific literature, including experimental in vitro and in vivo protocols. This detailed knowledge forms the AurSCOPE® database line, focusing on the human body's main therapeutic targets: GPCRs, Kinases, Ion Channels, Proteases and Nuclear Receptors. Additional AurSCOPE® databases relate to safety, toxicology, and pharmacokinetics (ADME, hERG). Headquartered in Paris, France, Aureus Pharma's information solutions are proven to streamline the discovery process for many of the world's most successful biopharmaceutical companies and leading research institutions.